PGR and breast cancer: The level of these 12 candidate microRNAs were quantified in plasma from early-stage BC patients, with the most common histotype and receptor profile in Lebanon (IDC and ER+/PR+) and compared to healthy controls to test for correlations between clinical and pathological data and their diagnostic ability.